New Diagnostics and Emerging Biomarkers for Alzheimer’s Disease, Upcoming Webinar Hosted by Xtalks
Toronto, ON (PRWEB) August 07, 2023 -- In an exciting development for Alzheimer's disease research, esteemed experts in the field from Labcorp will present a comprehensive webinar titled "New Diagnostics and Emerging Biomarkers for Alzheimer’s Disease." This webinar will illuminate recent advancements, discuss the establishment of the ATN research framework and delve into how this new paradigm is revolutionizing the understanding and treatment of Alzheimer’s disease.
Led by Robert Martone, Associate Director at the Biomarker Solution Center at Labcorp; Joe Volpe, Business Segment and Scientific Discipline Director of Neurology at Labcorp; and John W. Winslow, Associate Vice President of Research and Development at Labcorp (Monogram), the webinar promises to offer groundbreaking insights into this critical area of medical science.
In the course of the presentation, the speakers will address the current landscape of Alzheimer’s disease biomarkers and diagnostics, discussing blood-based biomarkers and the implications of Labcorp's recently launched ATN panel. This will encompass the role of emerging biomarkers like GFAP and YKL40 in supplementing the core ATN panel, enhancing our understanding of, and the ability to identify and differentiate, neurodegenerative diseases.
Labcorp, a global life sciences company, is at the forefront of diagnostic innovation, helping to improve health and improve lives worldwide. As part of their commitment to advancing the medical field, they have formed a strategic partnership with Xtalks to present this vital webinar.
We invite Biopharmaceutical Developers, Chief Medical Officers, Clinical and Research Directors, and all those involved in Alzheimer's research and treatment to attend. This webinar will provide a valuable opportunity to understand the evolving Alzheimer’s disease biomarker landscape, learn how the ATN panel can provide insight into patient risks for neurodegenerative conditions and comprehend the relationship between various biomarkers and their role in Alzheimer's research advancements.
The webinar, "New Diagnostics and Emerging Biomarkers for Alzheimer’s Disease," will take place on Thursday, August 24, 2023, at 11am EDT (4pm BST/UK). We encourage you to mark your calendars and join us for this essential and enlightening presentation.
For more information, or to register for this event, visit New Diagnostics and Emerging Biomarkers for Alzheimer’s Disease.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
Share this article